Arax Advisory Partners’s NEVRO CORP. NVRO Stock Holding History

Arax Advisory Partners’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-257	Closed	-$957	–	3103
2024 Q4	$957	Buy	257 +210	+447%	+$969	﹤0.01%	2188
2024 Q3	$263	Hold	47	–	–	﹤0.01%	2487
2024 Q2	$396	Buy	+47	New	+$501	﹤0.01%	2357
2023 Q4	–	Sell	-51	Closed	-$981	–	1446
2023 Q3	$981	Buy	+51	New	+$1.09K	﹤0.01%	1138
2021 Q4	–	Sell	-4	Closed	–	–	1202
2021 Q3	$0	Buy	+4	New	+$524	﹤0.01%	1086

Other funds holding NVRO

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OBAM

ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Arax Advisory Partners's NVRO Position: Q1 2025 in Review

Arax Advisory Partners sold out of NEVRO CORP. (NVRO) in Q1 2025, closing a stake of 257 shares — an estimated $957 sold.

Arax Advisory Partners first reported a position in NVRO in Q3 2021 and held it in 5 quarters. The position peaked at $981 in Q3 2023. 126 funds tracked by Wall St. Rank hold NVRO as of Q1 2025.

Arax Advisory Partners reported no remaining NEVRO CORP. position as of Q1 2025 after selling out during the quarter.
Arax Advisory Partners sold 257 NEVRO CORP. shares in Q1 2025, an estimated $957.
Arax Advisory Partners first reported a position in NEVRO CORP. in Q3 2021 and held it in 5 quarters.
Arax Advisory Partners's NEVRO CORP. position peaked at $981 in Q3 2023.
126 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2025.

Based on Arax Advisory Partners's 13F filing for Q1 2025, filed 15 May 2025.